The experiment is being conducted by Hvivo, a company that owns the Queen Mary BioEnterprises innovation center laboratory in Whitechapel, east London. 24 participants will be paid $ 4,500 each, they will be given less dangerous strains of the virus – 0C43 and 229E – and placed in quarantine for two weeks.
Doctors will closely monitor their condition and diet, probably experimental lung symptoms will appear, much less dangerous than from CoViD-2019. The most effective of the tested vaccines and drugs will be administered to real patients. Scientists expect that the new development will help in the fight against the epidemic and stop the global panic.
